An investigational drug-eluting stent called Xience, coated with everolimus, led to significantly less late lumen loss after nine months than did the Taxus (paclitaxel-eluting) stent, said researchers here today. March 2007
Crosser catheter proved successful for recanalization of a chronic total occlusion with mid-CTO tortuosity. The case illustrates the ability of the device to navigate a tortuous path of the occlusion within the true lumen without arterial dissection or pe